Other
Knee Arthroplasty
0
Pipeline Programs↗
6
Active Trials↗
2
Companies Involved↗
Knee Arthroplasty is an early-stage landscape with 0 programs across 2 companies. The most active players are TenNor Therapeutics Limited, Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
31
clinical trials
Completed20 · 65%
Recruiting4 · 13%
Unknown status4 · 13%
Enrolling by invitation1 · 3%
Terminated1 · 3%
Active, not recruiting1 · 3%
Clinical Trials
Trial Activity
31 trials
VTE Prevention Following Total Hip and Knee Arthroplasty
Recruiting·—·Phase 3·NCT04075240·5,400 enrolled
Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty
Active, not recruiting·—·Preclinical·NCT03153449·400 enrolled
High-Dose Steroid for Knee Arthroplasty
Completed·—·Phase 4·NCT03758170·160 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)